Study S001312

The Effect of Semaglutide on Osteoporotic Fractures in Patients With Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07165158
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: NOT_YET_RECRUITING
Enrollment: 150
Start: 2025-09-15
Primary completion: 2026-12-31
Lead sponsor: The First Affiliated Hospital of Xiamen University
Conditions: Osteoporosis; Osteoporosis Fracture; T2DM
Interventions: DRUG:semaglutide combined with metformin
Results posted: FALSE

Registered primary outcomes

lumbar bone mineral density [From enrollment to the end of treatment at 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.